Table 2. .
Patients’ Oncologic and Treatment Characteristics
| Variables | Total (n = 154) | PPM (n = 97) | ICD (n = 23) | CRT (n = 34) | P |
|---|---|---|---|---|---|
| Cancer type, No. (%) | .67 | ||||
| Solid | 96 (62) | 63 (65) | 13 (57) | 20 (59) | |
| Hematologic | 58 (38) | 34 (35) | 10 (43) | 14 (41) | |
| Cancer on active therapy at time of CIED placement, No. (%) | 99 (64) | 68 (70) | 12 (52) | 19 (56) | .14 |
| Cancer therapy received within 1 y before CIED placement, No. (%) | |||||
| Chemotherapy | 74 (48) | 45 (46) | 13 (57) | 16 (47) | .68 |
| Radiation therapy | 83 (54) | 48 (49) | 15 (65) | 20 (59) | .32 |
| Immunotherapy | 19 (12) | 11 (11) | 4 (17) | 4 (12) | .68 |
| HSCT | 13 (8) | 8 (8) | 1 (4) | 4 (12) | .70 |
| Type of HSCT | .67 | ||||
| Autologous | 8 (5) | 5 (5) | 0 (0) | 3 (9) | |
| Allogeneic | 5 (3) | 3 (3) | 1 (4) | 1 (3) | |
| Cancer therapy received within 1 y after CIED placement, No. (%) | |||||
| Chemotherapy | 52 (34) | 33 (34) | 6 (26) | 13 (38) | .63 |
| Radiation therapy | 21 (14) | 17 (18) | 2 (9) | 2 (6) | .22 |
| Immunotherapy | 14 (9) | 10 (10) | 0 (0) | 4 (12) | .25 |
| Surgery | 14 (9) | 14 (14) | 0 (0) | 0 (0) | .007 |
| HSCT | 5 (3) | 3 (3) | 2 (9) | 0 (0) | .17 |
| Type of HSCT | .052 | ||||
| Autologous | 3 (2) | 3 (3) | 0 (0) | 0 (0) | |
| Allogeneic | 2 (1) | 0 (0) | 2 (9) | 0 (0) | |
| Central IV access, at time of CIED placement, No. (%) | .36 | ||||
| None | 104 (68) | 64 (66) | 16 (70) | 24 (71) | |
| PICC | 18 (12) | 13 (13) | 1 (4) | 4 (12) | |
| Port-a-cath | 16 (10) | 9 (9) | 2 (9) | 5 (15) | |
| CVC | 13 (8) | 9 (9) | 4 (17) | 0 (0) | |
| Hemodialysis catheter | 3 (2) | 2 (2) | 0 (0) | 1 (3) |
Abbreviations: CIED, cardiac implantable electronic devices; CRT, cardiac resynchronization therapy; CVC, central venous catheter; HSCT, hematopoietic stem cell transplantation; ICD, implantable cardioverter defibrillator; IV, intravenous; PICC, peripheral inserted central catheter; PPM, permanent pacemaker.